NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Arktus Therapeutics Co., Ltd.

Arktus Therapeutics Co., Ltd.

Private
KyotoHealthcare & Life Scienceshttps://arktustx.com/

Last Round

Series A

Sep 22, 2025

Total Funding Raised

$7.32M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arktus Therapeutics Co., Ltd. is a biotechnology company that develops regenerative medicine for knee cartilage repair using iPS cell and 3D-printing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, 3D Printing, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinecartilage regenerationknee osteoarthritisiPS cells3D bioprintingcartilage implanttissue engineeringcell therapystem cell therapyinduced pluripotent stem cellsscaffold-free implantmesenchymal stem cellsMSCspre-clinical stageprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arktus Therapeutics Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Arktus Therapeutics Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arktus Therapeutics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2025
SeedApr 10, 2024

Arktus Therapeutics Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    Raised $4.46M from multiple venture capital firms.

  • Apr 10, 2024

    $2.86M round led by Kyoto University Innovation Capital

Arktus Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arktus Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arktus Therapeutics Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Year Founded2023
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.